MET-PE — MetLife, Inc.

Summary of MetLife (MET-PE) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Adjusted Earnings: $1.6 billion, or $2.49 per share; $2.58 per share excluding notable items, up 24% YoY.
• Full Year Adjusted Earnings: $6 billion, or $8.89 per share, reflecting a 10% increase YoY.
• Adjusted Return on Equity (ROE): 16%, within the target range of 15%-17%.
• Direct Expense Ratio: Improved to 11.7%, ahead of the five-year target of 11.3%.
• Free Cash Flow: $4.9 billion generated in 2025, contributing to a five-year target of $25 billion.
• Net Income: Approximately $800 million for Q4 and $3.2 billion for the full year.

2. Strategic Updates and Business Highlights

• New Frontier Strategy: Focused on growth, capital deployment, and operational efficiency.
• Group Benefits: Added $100 million in new adjusted premiums, with voluntary PFOs up 10% YoY.
• Pension Risk Transfer (PRT): Achieved record origination of over $14 billion, the highest annual total.
• Acquisition of PineBridge Investments: Closed in Q4, establishing MetLife Investment Management (MIM) as a new business segment with $742 billion in assets under management.
• International Growth: Asia sales increased 18% in constant currency, while Latin America saw a 12% rise.

3. Forward Guidance and Outlook

• 2026 Targets: Expect double-digit adjusted EPS growth and adjusted ROE to remain in the 15%-17% range.
• Group Benefits: Anticipate 7%-9% growth in adjusted earnings, supported by PFO growth.
• Retirement and Income Solutions (RIS): Expected adjusted earnings between $1.6 billion and $1.8 billion in 2026.
• Asia: Forecasted sales growth in the mid to high single digits and adjusted earnings growth in the mid-single digits.
• MetLife Investment Management: Projected revenue growth of approximately 30% in 2026.

4. Bad News, Challenges, or Points of Concern

• Disability Experience: Weaker than expected, with higher average severity and incidents impacting results.
• Surrender Activity: Increased surrender trends noted in Q4, particularly influenced by currency fluctuations.
• Investment Income: Variable investment income fell short of the 2025 target of $1.7 billion, totaling $1.5 billion.
• Potential Impact of Economic Variables: Macroeconomic volatility in Japan could affect sales and persistency.

5. Notable Q&A Insights

• Group Benefits Pricing: Positive renewal season results with improved persistency, particularly in dental.
• Japan Market: Macro volatility has led to higher surrenders, but the company remains optimistic about its competitive position.
• AI Impact: Management is aware of potential employment shifts due to AI but remains confident in growth opportunities across various segments.
• Reinsurance Strategy: Emphasized the importance of leveraging reinsurance to support growth in retirement solutions.

Overall, MetLife reported a strong performance in Q4 2025, demonstrating solid growth across several business segments while navigating challenges in the disability sector and macroeconomic pressures. The company remains focused on executing its strategic initiatives and achieving its long-term financial commitments.